Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Nyxoah SA (NYSE: NYXH) discloses information on the total number of voting rights and shares following the issuance of new shares. The share capital stands at EUR 4,927,355.12 with a total of 28,682,635 securities carrying voting rights, all ordinary shares. Nyxoah also reveals the existence of rights to subscribe to additional securities carrying voting rights through various ESOP Warrants.
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont-Saint-Guibert (Belgium), March 29, 2024, 9:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.
- Share capital: EUR 4,927,355.12
- Total number of securities carrying voting rights: 28,682,635 (all ordinary shares)
- Total number of voting rights (= denominator): 28,682,635 (all relating to ordinary shares)
- Number of rights to subscribe to securities carrying voting rights not yet issued:
- 100 “2018 ESOP Warrants” issued on December 12, 2018, entitling their holders to subscribe to a total number of 50,000 securities carrying voting rights (all ordinary shares);
- 400,500 “2020 ESOP Warrants” issued on February 21, 2020, entitling their holders to subscribe to a total number of 400,500 securities carrying voting rights (all ordinary shares); and
- 1,085,500 “2021 ESOP Warrants” issued on September 8, 2021, entitling their holders to subscribe to a total number of 1,085,500 securities carrying voting rights (all ordinary shares); and
- 700,000 “2022 ESOP Warrants” issued on December 28, 2022, entitling their holders to subscribe to a total number of 700,000 securities carrying voting rights (all ordinary shares).
*
* *
Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313
Nyxoah SA has a share capital of EUR 4,927,355.12.
There are 28,682,635 securities carrying voting rights for Nyxoah SA, all of which are ordinary shares.
ESOP Warrants are rights issued by Nyxoah SA that entitle holders to subscribe to additional securities carrying voting rights. These include the 2018, 2020, 2021, and 2022 ESOP Warrants.
Nyxoah SA issued 1,085,500 ‘2021 ESOP Warrants’ in 2021, entitling holders to subscribe to a total of 1,085,500 securities carrying voting rights, all ordinary shares.
David DeMartino serves as the Chief Strategy Officer of Nyxoah SA and can be contacted at david.demartino@nyxoah.com or +1 310 310 1313.
NASDAQ:NYXH
NYXH Rankings
#1765 Ranked by Stock Gains
NYXH Latest News
NYXH Stock Data
Surgical and Medical Instrument Manufacturing
Manufacturing
Belgium
Mont Saint Guibert
About NYXH
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA).
